| 248.1 | J01CE01 | benzylpenicilin (do 1 MU v jedné ampuli včetně) | parent. | 3.6 | GM | 123,86 | K |
| 01093 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x1mu | BTA | SK |
| 02136 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x500ku | BTA | SK |
| 248.2 | J01CE01 | benzylpenicilin (nad 1 MU v jedné ampuli) | parent. | 3.6 | GM | 49,32 | K |
| 93405 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x5mu | BTA | SK |
| 248.3 | J01CE08 | benzathin benzylpenicilin (do 0,6 MU v jedné ampuli včetně) | parent. | 2 | MU | 70,63 | K |
| 248.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2 | MU | 32,94 | K |
| 50160 | RETARPEN 2.4 M.U.I. | inj sic 50x2.4mu | BCW | A |
| 248.5 | J01CE09 | prokain penicilin (do 0,6 MU v jedné dávce včetně) | parent. | 2 | MU | 79,58 | K |
| 248.6 | J01CE09 | prokain penicilin (nad 0,6 MU v jedné dávce) | parent. | 2 | MU | 39,05 | K |
| 01102 | PROKAIN PENICILIN G BIOTIKA | inj 10x1.5mu | BTA | SK |
| 248.7 | J01CE30 | kombinace | parent. | 0.5 | DF | 10,36 | K |
| 02723 | PENDEPON COMPOSITUM | inj 10x1.5mu | BTA | SK |
| 249 | J01CF | vůči beta-laktamáze stabilní peniciliny | p.o. |
|---|
| 249.1 | J01CF02 | cloxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | |
| 249.2 | J01CF02 | cloxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 | |
| 249.3 | J01CF04 | oxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | |
| 02677 | OXACILIN 250 LECIVA | cps 60x250mg | LEX | CZ |
| 76201 | PROSTAPHLIN 500MG | cps 40x500mg | BMS | I |
| 249.4 | J01CF04 | oxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 |
| 250 | J01CF | vůči beta-laktamáze stabilní peniciliny | parent. | K |
|---|
| 250.1 | J01CF04 | oxacilin | parent. | 2 | GM | 98,74 | K |
| 92359 | PROSTAPHLIN 1000MG | inj sic 1x1000mg | BMS | I |
| 251 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny | p.o. |
|---|
| 251.1 | J01CR01 | ampicilin a inhibitor beta-laktamázy (pevné lékové formy) | p.o. | 1.5 | GM | 83,58 | |
| 251.2 | J01CR01 | ampicilin a inhibitor beta-laktamázy (tekuté lékové formy) | p.o. | 1.5 | GM | 80,90 | |
| 251.3 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1 | GM | 31,80 | |
| 251.4 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg do 625 mg včetně v 1 tabletě) | p.o. | 1 | GM | 28,98 | |
| 251.5 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 625 mg v 1 tabletě) | p.o. | 1 | GM | 27,18 | |
| 251.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1 | GM | 47,44 | |
| 53567 | CURAM 156.25MG/5ML | plv sus 1x100ml | BCA | A |
| 251.7 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1 | GM | 31,12 |
| 252 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny, nebo kombinace penicilinů | parent. | U/ATB |
|---|
| 252.1 | J01CR01 | ampicilin a enzymový inhibitor | parent. | 1,5 | GM | 121,63 | U/ATB |
| 252.2 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1 | GM | 106,50 | U/ATB |
| 72972 | AMOKSIKLAV 1.2GM | inj sic 5x1.2gm | LEK | SLO |
| 252.3 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15 | GM | 1820,84 | U/ATB |
| 252.4 | J01CR05 | piperacilin a inhibitor beta-laktamázy | parent. | 14 | GM | 1980,92 | U/ATB |
| 252.5 | J01CR50 | kombinace penicilinů | parent. | 3 | DF | 71,80 | U |
| 252.6 | J01DA | cefoperazon a inhibitor beta-laktamázy | parent. | 2 | GM | 397,00 | U/ATB |
| 253 | J01DA | cefalosporinová antibiotika | p.o. |
|---|
| 253.1 | J01DA01 | cefalexin (pevné lékové formy) | p.o. | 2 | GM | 38,13 |
| 66357 | OSPEXIN 1000MG | tbl obd 12x1000mg | BCA | A |
| 67212 | CEPHABENE 1000MG | tbl obd 20x1000mg | MCK | D |
| 67211 | CEPHABENE 1000MG | tbl obd 10x1000mg | MCK | D |
| 67208 | CEPHABENE 500MG | tbl obd 10x500mg | MCK | D |
| 67209 | CEPHABENE 500MG | tbl obd 20x500mg | MCK | D |
| 55779 | CEFACLEN 250 | cps 30x250mg | SLO | SK |
| 55782 | CEFACLEN 500 | cps 30x500mg | SLO | SK |
| 06158 | ORACEF | cps 16x500mg | KRK | SLO |
| 66356 | OSPEXIN 500MG | tbl obd 12x500mg | BCA | A |
| 253.2 | J01DA01 | cefalexin (tekuté lékové formy) | p.o. | 2 | GM | 44,33 |
| 66354 | OSPEXIN 250MG/5ML | gra sus 1x60ml | BCA | A |
| 66355 | OSPEXIN 375MG/5ML | gra sus 1x60ml | BCA | A |
| 253.3 | J01DA06 | cefuroxim axetil (pevné lékové formy) | p.o. | 1 | GM | 92,35 | |
| 253.4 | J01DA06 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | |
| 253.5 | J01DA08 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 72,88 | |
| 53153 | VERCEF 250 MG | cps 7x3 (blistr) | RXY | IND |
| 253.6 | J01DA08 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) | p.o. | 1.5 | GM | 103,11 | |
| 253.7 | J01DA08 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.5 | GM | 86,27 | |
| 53152 | VERCEF250 MG/5ML | plv sus 1x100 ml | RXY | IND |
| 253.8 | J01DA09 | Cefadroxil (pevné lékové formy) | p.o. | 2 | GM | 44,00 |
| 44802 | BIODROXIL | tbl obd 12x1000mg | BCA | A |
| 44799 | BIODROXIL | cps 12x500mg | BCA | A |
| 253.9 | J01DA09 | Cefadroxil (tekuté lékové formy) | p.o. | 2 | GM | 68,00 |
| 44807 | BIODROXIL 250MG/5ML | plv sus 1x60ml/3gm | BCA | A |
| 253.10 | J01DA23 | Cefixim | p.o. | 0.4 | GM | 107,35 | ATB |
| 253.11 | J01DA26 | Cefetamet | p.o. | 1 | GM | 107,53 | ATB |
| 253.12 | J01DA33 | Cefpodoxim | p.o. | 0.4 | GM | 92,35 | ATB |
| 253.13 | J01DA39 | Ceftibuten | p.o. | 0.4 | GM | 92,35 | ATB |
| 253.14 | J01DA08 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. | 1.5 | GM | 66,03 | |
| 53157 | VERCEF 500 MG | cps 7x3 (blistr) | RXY | IND |
| 253.15 | J01DA41 | cefprozil (pevné lékové formy) | p.o. | 1 | GM | 92,35 | |
| 253.16 | J01DA41 | cefprozil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | |
| 254 | J01DA | cefalosporinová antibiotika | parent. | U/ATB P |
|---|